Regenerative Medicine Market to Catapult to Over $35 Billion by 2019

Tuesday 16 April 2013, Amsterdam

This newly published “Regenerative Medicine Markets” report that the regenerative medicine market will catapult to over $35 billion by 2019.
    
Regenerative medicine (RM) can be categorized into three main modalities: tissue engineering, biomaterials and biomolecules, e.g., scaffolds, growth factors and stem cell therapy. Tissue-engineered bone products in the orthopedic segment will see steady growth, from $7.5 billion in 2012 to $3.29 billion in 2019. The up-and-coming cardiology and vascular products segment will also see substantial growth, reaching a market value of $3.29 over the forecast period.

The “Regenerative Medicine Markets” report covers:

• Tissue-engineered skin, cartilage, bone, peripheral nerves, corneas and blood vessels
• Sell culture products
• Stem cell transplants
• Pluripotent, neural, RPE and limbal stem cells
• Cartilage repair
• Skin ulcers
• Facial reconstruction bone
• Tendon, ligament and blood vessel repair
• Myocardial patches
• Heart valve repair
• Kidney repair
• Bladder repair
• Liver repair
• Bioartificial pancreas

    
The “Regenerative Medicine Markets” report examines companies manufacturing regenerative medicine equipment and supplies in the world

Companies covered include:

• Amorcyte,
• Ars Arthro,
• Axiogenesis,
• AxoGen,
• Bellicum,
• BetaStem,
• Bioheart,
• Biomet,
• BioMimetic,
• BioTissue,
• Biovest,
• BrainStorm Cell,
• California Stem Cell,
• Cardio3,
• Cellartis,
• CellSeed,
• Cellular,
• Chromocell,
• Cognate,
• Cook,
• Cytomedix,
• Cytonet,
• Cytori,
• DanDrit,
• Fibrocell,
• Forticell,
• Gamida,
• Harvest,
• Histogenics,
• Humacyte,
• Integra,
• Intercytex,
• iPierian,
• Japan Tissue Engineering,
• Kensey Nash,
• Kiadis,
• Life Cell,
• Living Cell,
• MaxCyte,
• MediStem,
• Mesoblast,
• MolMed,
• NanoCor,
• Neuralstem,
• NeuroNova,
• NewLink Genetics,
• Olympus Terumo,
• OncoMed,
• Opexa,
• Organogenesis,
• Orthovita,
• Osiris,
• Osteotech,
• Pervasis,
• Pluristem,
• Proneuronnologies,
• RegeneRx,
• ReNeuron,
• Revivicor,
• SanBio,
• Saneron,
• Sangamo,
• Stem Cell Authority,
• StemCells,
• Stemline,
• Stratetech,
• Synthecon,
• Tengion,
• Thermogenesis,
• TiGenics,
• Tissue Genesis,
• ViaCyte,
• Vistagen and Zen-Bio.